- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02809066
Dietary Calcium Intake in Premenstrual Syndrome
June 21, 2016 updated by: Merve YURT, Eastern Mediterranean University
Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome
This study was planned and conducted to investigate effect of adequate calcium intake on Premenstrual Syndrome (PMS) symptoms in women with PMS who have inadequate calcium intake.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study was planned and conducted to investigate effect of adequate calcium intake on Premenstrual Syndrome (PMS) symptoms in women with PMS who have inadequate calcium intake.
Thirty one women, aged between 20-28 years, diagnosed with PMS and suitable for inclusion criteria, were participated in study.
Participants were allocated to intervention (n=16) and control (n=15) groups randomly.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Mersin, Turkey
- Eastern Mediterranean University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 28 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Women with;
- PMS who have inadequate calcium intake
- Regular menstrual cycle
- Menstrual flow which occurs every 22 to 35 days and last three to eight days
Exclusion Criteria:
- Having any of metabolic diseases
- Use oral contraceptive pill
- user vitamins and minerals supplements
- being smoker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interventional group
8-week follow- up with dietary sufficient calcium intake
|
Intervention group was ensured to take at least 1000 mg calcium from foods, 700-800 mg of it from dairy and dairy products, according to Recommended Dietary Allowances (RDA), for two months. These foods were;
|
No Intervention: Control group
8-week follow- up with no specific diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Premenstrual Syndrome Scale (PMSS)
Time Frame: Eight weeks
|
Premenstrual Syndrome Scale (PMSS) was used for symptom assessment at initial and after two menstrual cycles.
|
Eight weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in Quality of life scale Short Form (SF-36)
Time Frame: Eight weeks
|
Eight weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Merve Yurt, MS, Eastern Mediterranean University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
June 16, 2016
First Submitted That Met QC Criteria
June 21, 2016
First Posted (Estimate)
June 22, 2016
Study Record Updates
Last Update Posted (Estimate)
June 22, 2016
Last Update Submitted That Met QC Criteria
June 21, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015/10-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premenstrual Syndrome
-
Esra ÖZERKTO Karatay UniversityRecruitingPremenstrual Syndrome-PMSTurkey
-
Shaare Zedek Medical CenterUnknownPremenstrual Syndrome-PMS
-
Philipps University Marburg Medical CenterLinkoeping UniversityCompletedPremenstrual Syndrome (PMS)Germany
-
Cairo UniversityNot yet recruitingPremenstrual Tension
-
Cairo UniversityNot yet recruitingPremenstrual Pain
-
Terra Biological LLCCompletedPremenstrual Syndrome (PMS)
-
Massachusetts General HospitalWithdrawnPremenstrual Dysphoric Disorder | Premenstrual Syndrome | Premenstrual Tension | Menstrual Related Mood DisorderUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownDepression | Premenstrual Dysphoric Disorder (PMDD)Israel
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedPremenstrual SyndromeUnited States
Clinical Trials on Sufficient dietary calcium intake in premenstrual syndrome
-
University of LeedsCompletedHip Fracture (First Incidence of)United Kingdom
-
International Agency for Research on CancerFederico II University; Imperial College London; Fondazione IRCCS Istituto Nazionale... and other collaboratorsCompleted
-
The University of Tennessee, KnoxvilleCompleted
-
University of FloridaCompletedHematopoietic NeoplasmUnited States
-
Pennington Biomedical Research CenterCompleted
-
International Medical UniversityTate & LyleCompleted
-
University of CalgaryCompletedMetabolic Syndrome | Type 2 Diabetes | Impaired Glucose ToleranceCanada
-
University of TorontoUnknownCardiovascular Diseases | Mortality | Metabolic Syndrome | Type 2 Diabetes | AdiposityCanada
-
Johns Hopkins Bloomberg School of Public HealthMedifast, Inc.Completed
-
University of AberdeenUniversity of JazanActive, not recruiting